SPDR® MSCI World Health Care UCITS ETF (WHEA:LSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the SPDR® MSCI World Health Care UCITS ETF stock forecast from 0 analysts, the average analyst target price for SPDR® MSCI World Health Care UCITS ETF is not available over the next 12 months. SPDR® MSCI World Health Care UCITS ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of SPDR® MSCI World Health Care UCITS ETF is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, SPDR® MSCI World Health Care UCITS ETF’s stock price was USD 59.64. SPDR® MSCI World Health Care UCITS ETF’s stock price has changed by +1.08% over the past week, -3.48% over the past month and +3.05% over the last year.
No recent analyst target price found for SPDR® MSCI World Health Care UCITS ETF
No recent average analyst rating found for SPDR® MSCI World Health Care UCITS ETF
Company Overview SPDR® MSCI World Health Care UCITS ETF
Frequently Asked Questions About SPDR® MSCI World Health Care UCITS ETF (WHEA:LSE) Stock
Stock Target Advisor's fundamental analysis for SPDR® MSCI World Health Care UCITS ETF's stock is Very Bullish.
Unfortunately we do not have enough data on WHEA:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on WHEA:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on WHEA:LSE's stock to indicate if its overvalued.
The last closing price of WHEA:LSE's stock was USD 59.64.
The most recent market capitalization for WHEA:LSE is USD 0.59B.
Unfortunately we do not have enough analyst data on WHEA:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains SPDR® MSCI World Health Care UCITS ETF's stock.
Sorry, we do not have any data on the number of employees for SPDR® MSCI World Health Care UCITS ETF.
Sorry we do not have any infomation available on SPDR® MSCI World Health Care UCITS ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for WHEA:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
